Trusted News Discovery Since 2008
{{/content}}
WHO set to resume hydroxychloroquine trial to battle covid-19
Video Credit: HT Digital Content
Published on June 4, 2020 - Duration: 02:33s
WHO set to resume hydroxychloroquine trial to battle covid-19
World Health Orgnanisation (WHO) said hydroxychloroquine (HCQ) will return to solidarity trial for potential treatment covid-19.
The UN body had paused trials of the anti-malarial drug citing a Lancet study.
The study had suggested the drug could cause more fatalities among Covid-19 patients.
At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said, “The Executive Group received this recommendation and endorsed continuation of all arms of the solidarity trial, including hydroxychloroquine.” Watch the video for more.
You are here
Related videos from verified sources
India-China Galwan faceoff: China releases 10 Indian soldiers from custody | Oneindia News 03:00
Video credit: Oneindia - Published on June 19, 2020
Trump Criticizes FDA Over Hydroxychloroquine Decision 00:32
Video credit: Wochit Tech - Published on June 16, 2020
FDA Pulls Emergency Authorization For Hydroxychloroquine 00:37
Video credit: Wochit Entertainment - Published on June 15, 2020